Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022
Conference Call Details: |
|
Date: |
|
Time: |
|
|
1-833-953-2434 ( |
(telephonic replay through |
1-877-344-7529 ( |
Webcast: (online replay through |
About Harrow
Harrow (Nasdaq: HROW) is an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies that are accessible and affordable. For more information about Harrow, including investor-related materials, please visit the corporate website, harrowinc.com, or Harrow’s LinkedIn page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221027005179/en/
jwebb@harrowinc.com
615-733-4737
Source: Harrow